Impact of Follicle Size at Trigger on Reproductive Outcomes in Letrozole-Modified Natural Frozen Embryo Transfer Cycles in High Responder Patients
Authors:
- 13 November 2025
- journal article
- assisted reproduction-technologies
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 43 (1) , 179-185
Abstract
Purpose To evaluate whether follicle size at hCG trigger influences reproductive outcomes in letrozole-modified natural frozen embryo transfer (let-mNC-FET) cycles among high-responder patients. Methods This observational cohort included 170 let-mNC-FET cycles. Patients were stratified by follicle-size percentiles at trigger: 0–25th (15–17 mm; n = 43), 25–75th (18–20 mm; n = 90), and > 75th (21–24 mm; n = 37). Oral dydrogesterone provided luteal support. Serum progesterone (P4) on embryo-transfer (ET) day was measured with an assay that does not detect dydrogesterone (reflecting endogenous luteal production). The primary outcome was the ongoing pregnancy rate (OPR). Group comparisons used ANOVA/Kruskal–Wallis and χ2 tests; predictors of OPR were evaluated with logistic regression. Results Positive hCG and OPR did not differ across percentile groups (51.2%, 52.2%, 55.6%; p = 0.920 and 48.8%, 50.0%, 52.7%; p = 0.833, respectively). Endometrial thickness at trigger differed by group (medians 8.0, 9.0, 7.8 mm; p < 0.001), while ET-day P4 increased with larger follicles (medians 19.74, 21.00, 26.50 ng/mL; p = 0.001; post-hoc 0–25th vs > 75th p = 0.0009). In multivariable analysis, younger age (aOR 0.834; 95% CI 0.762–0.914; p = 0.0001), higher BMI (aOR 1.169; 1.015–1.346; p = 0.0303), fewer stimulation days (aOR 0.798; 0.647–0.983; p = 0.0343), larger leading follicle size (aOR 1.343; 1.059–1.703; p = 0.0151), and higher ET-day P4 (aOR 1.067; 1.027–1.108; p = 0.0007) independently predicted OPR; EMT and AMH were not associated (p ≥ 0.08 and p = 0.25). Conclusions Although OPR did not differ across follicle-size strata, larger follicle size at trigger and higher endogenous luteal P4 were independent predictors of OPR in highresponders. Confirmation in adequately powered prospective studies is warranted.Keywords
This publication has 24 references indexed in Scilit:
- Cycle regimens for endometrial preparation prior to frozen embryo transferCochrane Database of Systematic Reviews, 2025
- Optimal follicle size for human chorionic gonadotropin trigger in mono-follicular growth during letrozole-induced intrauterine insemination cycles: findings from a large retrospective studyFertility and Sterility, 2025
- Preconception and Early-Pregnancy Body Mass Index in Women and Men, Time to Pregnancy, and Risk of MiscarriageJAMA Network Open, 2024
- The combination of dydrogesterone and micronized vaginal progesterone can render serum progesterone level measurements on the day of embryo transfer and rescue attempts unnecessary in an HRT FET cycleJournal of Assisted Reproduction and Genetics, 2024
- Letrozole use in vitrified single-blastocyst transfer cycles is associated with lower risk of large for gestational age infants in patients with polycystic ovary syndromeJournal of Assisted Reproduction and Genetics, 2023
- Individualized luteal phase support using additional oral dydrogesterone in artificially prepared frozen embryo transfer cycles: is it beneficial?Reproductive BioMedicine Online, 2023
- Oral, vaginal or intramuscular progesterone in programmed frozen embryo transfer cycles: a pilot randomized controlled trialReproductive BioMedicine Online, 2022
- Potential role of the corpus luteum in maternal cardiovascular adaptation to pregnancy and preeclampsia riskAmerican Journal of Obstetrics and Gynecology, 2022
- Optimal endometrial thickness in fresh and frozen-thaw in vitro fertilization cycles: an analysis of live birth rates from 96,000 autologous embryo transfersFertility and Sterility, 2022
- What is the optimal follicular size before triggering ovulation in intrauterine insemination cycles with clomiphene citrate or letrozole? An analysis of 988 cyclesFertility and Sterility, 2012